Effects of chronic and acute consumption of fruit- and vegetable-puree- based drinks on vasodilation, risk factors for CVD and the response as a result of the eNOS G298T polymorphism

Proceedings of the Nutrition Society

Volumn 68, Issue 2, 2009, Pages 148-161

  George, Trevor W ^a   Niwat, Chutamat ^a   Waroonphan, Saran ^a   Gordon, Michael H ^a   Lovegrove, Julie A ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Carotenoids; CVD; Flavonoids; Laser Doppler imaging

Indexed keywords

ASCORBIC ACID; CAROTENOID; GLUCOSE; INSULIN; NITRATE; NITRITE; URIC ACID; ALPHA TOCOPHEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOOD INTAKE; FRUIT; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; URIC ACID BLOOD LEVEL; URINALYSIS; VEGETABLE; ARTICLE; BEVERAGE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DIET; DRUG EFFECT; GENETICS; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; ASCORBIC ACID; BEVERAGES; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAROTENOIDS; CROSS-OVER STUDIES; DIET; ENDOTHELIUM, VASCULAR; FEMALE; FRUIT; GENOTYPE; HUMANS; INSULIN; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; RISK FACTORS; VASODILATION; VEGETABLES; VITAMIN E;

EID: 68149153088     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665109001165     Document Type: Conference Paper

References (88)

1. Allender S, Scarborough P, Peto V et al. (2008) European Cardiovascular Disease Statistics 2008. London: BHF; available at http://www.heartstats.org/ datapage.asp?id=7683
2. Bonetti PO, Lerman LO & Lerman A (2003) Endothelial dysfunction - A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23, 168-175.
3. Zeiher AM (1996) Endothelial vasodilator dysfunction: Pathogenetic link to myocardial ischaemia or epiphenomenon. Lancet 348, S10-S12.
4. Brown AA & Hu FB (2001) Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 73, 673-686.
5. Lopez-Garcia E, Schulze MB, Fung TT et al. (2004) Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 80, 1029-1035.
6. Ludmer PL, Selwyn AP, Shook TL et al. (1986) Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315, 1046-1051.
7. Kuvin JT & Karas RH (2003) Clinical utility of endothelial function testing - Ready for prime time? Circulation 107, 3243-3247.
8. Sattar N, Petrie JR & Jaap AJ (1998) The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. Atherosclerosis 138, 229-235.
9. Sattar N & Ferns G (2005) Endothelial dysfunction. In Cardiovascular Disease: Diet Nutrition and Emerging Risk Factors, pp. 63-77 [S Stanner, editor]. Oxford: Blackwell Science.
10. Anderson TJ, Uehata A, Gerhard MD et al. (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26, 1235-1241.
11. Ferrell WR, Ramsay JE, Brooks N et al. (2002) Elimination of electrically induced iontophoretic artefacts: Implications for non-invasive assessment of peripheral microvascular function. J Vasc Res 39, 447-455.
12. Jagren C, Gazelius B, Ihrman-Sandal C et al. (2002) Skin microvascular dilatation response to acetylcholine and sodium nitroprusside in peripheral arterial disease. Clin Physiol Funct Imaging 22, 370-374.
13. Wilmink HW, Stroes ESG, Erkelens WD et al. (2000) Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol 20, 185-188.
14. Devaraj S, Li D & Jialal I (1996) The effects of alpha tocopherol supplementation on monocyte function - Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J Clin Invest 98, 756-763.
15. Chambers JC, McGregor A, Jean-Marie J et al. (1999) Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia - An effect reversible with vitamin C therapy. Circulation 99, 1156-1160.
16. Andriambeloson E, Magnier C, Haan-Archipoff G et al. (1998) Natural dietary polyphenolic compounds cause endothelium- dependent vasorelaxation in rat thoracic aorta. J Nutr 128, 2324-2333.
17. Taubert D, Berkels R, Klaus W et al. (2002) Nitric oxide formation and corresponding relaxation of porcine coronary arteries induced by plant phenols: Essential structural features. J Cardiovasc Pharmacol 40, 701-713.
18. Suganuma H & Inakuma T (1999) Protective effect of dietary tomato against endothelial dysfunction in hypercholesterolemic mice. Biosci Biotechnol Biochem 63, 78-82.
19. Brock DW, Davis CK, Irving BA et al. (2006) A highcarbohydrate, high-fiber meal improves endothelial function in adults with the metabolic syndrome. Diabetes Care 29, 2313-2315.
20. Malinow MR, Bostom AG & Krauss RM (1999) Homocyst( e)ine, diet, and cardiovascular diseases - A statement for healthcare professionals from the Nutrition Committee American Heart Association. Circulation 99, 178-182.
21. McDowell IFW & Lang D (2000) Homocysteine and endothelial dysfunction: A link with cardiovascular disease. J Nutr 130, 369S-372S.
22. Pruefer D, Scalia R & Lefer AM (1999) Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide. Gen Pharmacol 33, 487-498. (Pubitemid 30047154)
23. Tsai JC, Perrella MA, Yoshizumi M et al. (1994) Promotion of vascular smooth-muscle cell-growth by homocysteine - A link to atherosclerosis. Proc Natl Acad Sci USA 91, 6369-6373.
24. Dudman NPB, Temple SE, Guo XW et al. (1999) Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ Res 84, 409-416.
25. Van den Berg M, Boers GHJ, Franken DG et al. (1995) Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest 25, 176-181.
26. Verhaar MC, Wever RMF, Kastelein JJP et al. (1999) Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia - A randomized placebocontrolled trial. Circulation 100, 335-338.
27. Bellamy MF, McDowell IFW, Ramsey MW et al. (1999) Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. Eur J Clin Invest 29, 659-662.
28. Woo KS, Chook P, Lolin YI et al. (1999) Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 34, 2002-2006.
29. Andersson TLG, Matz J, Ferns GAA et al. (1994) Vitamin E reverses cholesterol-induced endothelial dysfunction in the rabbit coronary circulation. Atherosclerosis 111, 39-45.
30. Stewartlee AL, Forster LA, Nouroozzadeh J et al. (1994) Vitamin E protects against impairment of endotheliummediated relaxations in cholesterol-fed rabbits. Arterioscler Thromb 14, 494-499.
31. Wu DY, Koga T, Martin KR et al. (1999) Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis 147, 297-307.
32. Faruqi R, Delamotte C & Dicorleto PE (1994) Alphatocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 94, 592-600.
33. Fontana L, Mcneill KL, Ritter JM et al. (1999) Effects of vitamin C and of a cell permeable superoxide dismutase mimetic on acute lipoprotein induced endothelial dysfunction in rabbit aortic rings. Br J Pharmacol 126, 730-734.
34. Weber C, Erl W, Weber K et al. (1996) Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 93, 1488-1492.
35. Davi G, Romano M, Mezzetti A et al. (1998) Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 97, 953-957.
36. Beckman JA, Goldfine AB, Gordon MB et al. (2001) Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 103, 1618-1623.
37. Hornig B, Arakawa N, Kohler C et al. (1998) Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 97, 363-368.
38. Gokce N, Keaney JF, Frei B et al. (1999) Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 99, 3234-3240.
39. Neunteufl T, Priglinger U, Heher S et al. (2000) Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. J Am Coll Cardiol 35, 277-283.
40. Ischiropoulos H (1998) Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 356, 1-11.
41. Bendich A, Machlin LJ, Scandurra O et al. (1986) The antioxidant role of vitamin C. Adv Free Radic Biol Med 2, 419-444.
42. Jackson TS, Xu AM, Vita JA et al. (1998) Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83, 916-922.
43. May JM (2000) How does ascorbic acid prevent endothelial dysfunction? Free Radic Biol Med 28, 1421-1429.
44. Keaney JF, Simon DI, Stamler JS et al. (1993) NO forms an adduct with serum albumin that has endotheliumderived relaxing factor like properties. J Clin Invest 91, 1582-1589.
45. Scorza G, Pietraforte D & Minetti M (1997) Role of ascorbate and protein thiols in the release of nitric oxide from S-nitroso-albumin and S-nitroso-glutathione in human plasma. Free Radic Biol Med 22, 633-642.
46. Jia L, Bonaventura C, Bonaventura J et al. (1996) S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control. Nature 380, 221-226. (Pubitemid 26090643)
47. Patel RP, Hogg N, Spencer NY et al. (1999) Biochemical characterization of human S-nitrosohemoglobin - Effects on oxygen binding and transnitrosation. J Biol Chem 274, 15487-15492.
48. Heller R, Munscher-Paulig F, Grabner R et al. (1999) Lascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem 274, 8254-8260.
49. Hofmann H & Schmidt H (1995) Thiol dependence of nitric oxide synthase. Biochemistry 34, 13443-13452.
50. Kojima S, Ona S, Iizuka I et al. (1995) Antioxidative activity of 5,6,7,8-tetrahydrobiopterin and its inhibitory effect on paraquat-induced cell toxicity in cultured rat hepatocytes. Free Radic Res 23, 419-430.
51. Oshima S, Ojima F, Sakamoto H et al. (1996) Supplementation with carotenoids inhibits singlet oxygen-mediated oxidation of human plasma low-density lipoprotein. J Agric Food Chem 44, 2306-2309.
52. Kohlmeier L, Kark JD, Gomezgracia E et al. (1997) Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol 146, 618-626. (Pubitemid 27454549)
53. Keaney JF, Gaziano JM, Xu AM et al. (1993) Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci USA 90, 11880-11884.
54. Dimascio P, Murphy ME & Sies H (1991) Antioxidant defense systems - the role of carotenoids tocopherols, and thiols. Am J Clin Nutr 53, S194-S200.
55. Achan V, Tran CTL, Arrigoni F et al. (2002) all-transretinoic acid increases nitric oxide synthesis by endothelial cells - A role for the induction of dimethylarginine dimethylaminohydrolase. Circ Res 90, 764-769.
56. Leiper JM, Maria JS, Chubb A et al. (1999) Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 343, 209-214.
57. Miyazaki H, Matsuoka H, Cooke JP et al. (1999) Endogenous nitric oxide synthase inhibitor - A novel marker of atherosclerosis. Circulation 99, 1141-1146. (Pubitemid 29120084)
58. Boger RH, Bode-Boger SM, Szuba A et al. (1998) Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction - Its role in hypercholesterolemia. Circulation 98, 1842-1847.
59. Cherubini A, Vigna GB, Zuliani G et al. (2005) Role of antioxidants in atherosclerosis: Epidemiological and clinical update. Curr Pharm Des 11, 2017-2032.
60. Fitzpatrick DF, Hirschfield SL & Coffey RG (1993) Endothelium- dependent vasorelaxing activity of wine and other grape products. Am J Physiol 265, H774-H778.
61. Fitzpatrick DF, Hirschfield SL, Ricci T et al. (1995) Endothelium- dependent vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol 26, 90-95.
62. Stoclet J-C, Chataigneau T, Ndiaye M et al. (2004) Vascular protection by dietary polyphenols. Eur J Pharmacol 500, 299-313.
63. Dimmeler S, Fleming I, Fisslthaler B et al. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601-605.
64. Andriambeloson E, Stoclet JC & Andriantsitohaina R (1999) Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta. J Cardiovasc Pharmacol 33, 248-254.
65. Stoclet JC, Kleschyov A, Andriambeloson E et al. (1999) Endothelial NO release caused by red wine polyphenols. J Physiol Pharmacol 50, 535-540.
66. Wallerath T, Deckert G, Ternes T et al. (2002) Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106, 1652-1658.
67. Wallerath T, Poleo D, Li HG et al. (2003) Red wine increases the expression of human endothelial nitric oxide synthase - A mechanism that may contribute to its beneficial cardiovascular effects. J Am Coll Cardiol 41, 471-478.
68. Youdim KA, Martin A & Joseph JA (2000) Incorporation of the elderberry anthocyanins by endothelial cells increases protection against oxidative stress. Free Radic Biol Med 29, 51-60.
69. Serraino I, Dugo L, Dugo P et al. (2003) Protective effects of cyanidin-3-O-glucoside from blackberry extract against peroxynitrite-induced endothelial dysfunction and vascular failure. Life Sci 73, 1097-1114.
70. Freedman JE, Parker C, Li LQ et al. (2001) Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103, 2792-2798.
71. Whelan AP, Sutherland WHF, Mccormick MP et al. (2004) Effects of white and red wine on endothelial function in subjects with coronary artery disease. Intern Med J 34, 224-228.
72. Duffy SJ, Keaney JF, Holbrook M et al. (2001) Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104, 151-156. (Pubitemid 32655830)
73. Vita JA (2005) Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr 81, 292S-297S.
74. Tomas-Barberen FA & Clifford MN (2000) Flavanones, chalcones and dihydrochalcones - nature, occurrence and dietary burden. J Sci Food Agric 80, 1073-1080.
75. Hollman PCH & Arts ICW (2000) Flavonols, flavones and flavanols - nature, occurrence and dietary burden. J Sci Food Agric 80, 1081-1093.
76. Schroeter H, Heiss C, Balzer J et al. (2006) (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103, 1024-1029.
77. Moncada S & Higgs A (1993) Mechanisms of disease - The L-arginine-nitric oxide pathway. N Engl J Med 329, 2002-2012.
78. Hingorani AD, Liang CF, Fatibene J et al. (1999) A common variant of the endothelial nitric oxide synthase (Glu(298) → Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100, 1515-1520.
79. Hibi K, Ishigami T, Tamura K et al. (1998) Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32, 521-526.
80. Miyamoto Y, Saito Y, Kajiyama N et al. (1998) Positive association of Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension. J Hypertens 16, S55-S55.
81. Shimasaki Y, Yasue H, Yoshimura M et al. (1998) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31, 1506-1510. (Pubitemid 28273291)
82. Yoshimura M, Yasue H, Nakayama M et al. (1998) A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103, 65-69. (Pubitemid 28398388)
83. Liau LS, Lee BL, New AL et al. (1993) Determination of plasma ascorbic-acid by high-performance liquid chromatography with ultraviolet and electrochemical detection. J Chromatogr 612, 63-70.
84. Ross MA (1994) Determination of ascorbic acid and uric acid in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl 657, 197-200.
85. Thurnham DI, Smith E & Flora PS (1988) Concurrent liquidchromatographic assay of retinol, alpha-tocopherol, betacarotene, alpha-carotene, lycopene, and beta-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 34, 377-381.
86. Green LC, Wagner DA, Glogowski J et al. (1982) Analysis of nitrate, nitrite, and [N-15]-labeled nitrate in biological fluids. Anal Biochem 126, 131-138.
87. Felgines C, Talavera S, Gonthier MP et al. (2003) Strawberry anthocyanins are recovered in urine as glucuroand sulfoconjugates in humans. J Nutr 133, 1296-1301.
88. Godfrey V, Chan SL, Cassidy A et al. (2007) The functional consequence of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in young healthyvolunteers. Cardiovasc Drug Rev 25, 280-288.